Sartorius Aktiengesellschaft (FRA:SRT)

Market Cap	12.41B
Revenue (ttm)	3.47B
Net Income (ttm)	104.10M
Shares Out	n/a
EPS (ttm)	n/a
PE Ratio	119.24
Forward PE	33.10
Dividend	0.73 (0.45%)
Ex-Dividend Date	Mar 28, 2025

Volume	n/a
Average Volume	220
Open	157.20
Previous Close	159.40
Day's Range	157.20 - 157.20
52-Week Range	138.20 - 229.50
Beta	n/a
RSI	45.68
Earnings Date	Oct 16, 2025

About FRA:SRT

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors; software apps for bioreactors and cell culture shake flasks; fermenters; cell culture media, biolayer interferometry, microbiological testing, and fluid management products; buffers; reagents; plasmids; cellcelector flexs, incubator flowboxes, nanowell arrays, and capillaries and tips; high-throughput screening by cy...

• Industry: Laboratory Analytical Instruments
• Founded: 1870
• Employees: 13,528
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: SRT

Financial Performance

In 2024, FRA:SRT's revenue was 3.38 billion, a decrease of -0.44% compared to the previous year's 3.40 billion. Earnings were 84.00 million, a decrease of -59.14%.